NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025
A Contract Award Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- 2 year (est.)
- Value
- £925M
- Sector
- HEALTH
- Published
- 29 Jul 2025
- Delivery
- 01 Sep 2025 to 31 Aug 2027 (est.)
- Deadline
- n/a
Concepts
Location
Please refer to Document 3, Schedule 8 in the ITO Documents for the list of purchasing points
2 buyers
- NHS England London
21 suppliers
- Biogen Maidenhead
- Amgen Cambridge
- Sobi Swedish Orphan Biovitrum Abington
- Zentiva Pharma Guildford
- Fresenius Kabi Runcorn
- Sandoz Bracknell
- Thornton & Ross Slaithwaite
- Roche Products Welwyn Garden City
- Accord Barnstable
- Glaxosmithkline London
- Samsung Bioepis Brentford
- Pfizer Tadworth
- Janssen Cilag High Wycombe
- Celltrion Healthcare Uxbridge
- Abbvie Maidenhead
- Takeda London
- Organon Pharmaceuticals London
- Alexion Pharmaceuticals London
- Orifarm Hemel Hempstead
- Curateq Biologics Sro Prague
- Drreddys Laboratories Cambridge
Description
NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026
Lot Division
1 | CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 |
2 | CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE Eculizumab and Ravulizumab for London & SOFE |
Award Detail
1 | Biogen (Maidenhead)
|
2 | Amgen (Cambridge)
|
3 | Sobi Swedish Orphan Biovitrum (Abington)
|
4 | Zentiva Pharma (Guildford)
|
5 | Fresenius Kabi (Runcorn)
|
6 | Sandoz (Bracknell)
|
7 | Thornton & Ross (Slaithwaite)
|
8 | Roche Products (Welwyn Garden City)
|
9 | Accord (Barnstable)
|
10 | Glaxosmithkline (London)
|
11 | Samsung Bioepis (Brentford)
|
12 | Pfizer (Tadworth)
|
13 | Janssen Cilag (High Wycombe)
|
14 | Celltrion Healthcare (Uxbridge)
|
15 | Abbvie (Maidenhead)
|
16 | Takeda (London)
|
17 | Organon Pharmaceuticals (London)
|
18 | Alexion Pharmaceuticals (London)
|
19 | Orifarm (Hemel Hempstead)
|
20 | Curateq Biologics Sro (Prague)
|
21 | Drreddys Laboratories (Cambridge)
|
22 | Amgen (Cambridge)
|
23 | Samsung Bioepis (Brentford)
|
24 | Alexion Pharmaceuticals (London)
|
Award Criteria
PRICE | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
- Award on basis of price.
Other Information
Price is not the only award criterion and all criteria are stated in the procurement documents.
Reference
- FTS 043951-2025